Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Watkins

Showing results (611-620 of 1,127) with videos related to

Pageof 113
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 11, 2011
Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independentSarah J Watkins, Gillian M Borthwick, Rachael Oakenfull, et al.
Brain Research|April 23, 2003
Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cellsU Ingrid Richardson, Carol J Watkins, Celine Pierre, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Enhancement of the anti-hypertensive effect of methyldopa and other anti-hypertensive drugs by carbidopa in spontaneously hypertensive ratsA Scriabine, C T Ludden, C A Stone, et al.
Stroke|December 3, 1999
Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious ratsJ K Callaway, M J Knight, D J Watkins, et al.
British Journal of Anaesthesia|January 1, 1989
Fatal haemopathological consequences of general anaesthesiaP J Wright, J R Shortland, J D Stevens, et al.
Clinical and Experimental Immunology|May 1, 1990
C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosusG Wild, J Watkins, A M Ward, et al.
JBJS Case Connector|December 21, 2023
Posterior Tibiotalar Impingement After Pediatric Ankle Fracture Surgical Fixation: A Case ReportDavid S Liu, Ian T Watkins, Taylor Adams, et al.
Neurotoxicology|October 7, 2000
Residual neurologic deficits 30 years after occupational exposure to elemental mercuryR Letz, F Gerr, D Cragle, et al.
Immunopharmacology|February 26, 1998
Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibilityN J Watkins, P Braidley, C J Bray, et al.
International Journal of Epidemiology|March 1, 1982
Doctor diagnosis and maternal recall of lower respiratory illnessC J Watkins, P Burton, S Leeder, et al.
Pageof 113

Showing results (611-620 of 1,127) with videos related to

Sort By:
Pageof 113
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 11, 2011
Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independentSarah J Watkins, Gillian M Borthwick, Rachael Oakenfull, et al.
Brain Research|April 23, 2003
Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cellsU Ingrid Richardson, Carol J Watkins, Celine Pierre, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Enhancement of the anti-hypertensive effect of methyldopa and other anti-hypertensive drugs by carbidopa in spontaneously hypertensive ratsA Scriabine, C T Ludden, C A Stone, et al.
Stroke|December 3, 1999
Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious ratsJ K Callaway, M J Knight, D J Watkins, et al.
British Journal of Anaesthesia|January 1, 1989
Fatal haemopathological consequences of general anaesthesiaP J Wright, J R Shortland, J D Stevens, et al.
Clinical and Experimental Immunology|May 1, 1990
C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosusG Wild, J Watkins, A M Ward, et al.
JBJS Case Connector|December 21, 2023
Posterior Tibiotalar Impingement After Pediatric Ankle Fracture Surgical Fixation: A Case ReportDavid S Liu, Ian T Watkins, Taylor Adams, et al.
Neurotoxicology|October 7, 2000
Residual neurologic deficits 30 years after occupational exposure to elemental mercuryR Letz, F Gerr, D Cragle, et al.
Immunopharmacology|February 26, 1998
Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibilityN J Watkins, P Braidley, C J Bray, et al.
International Journal of Epidemiology|March 1, 1982
Doctor diagnosis and maternal recall of lower respiratory illnessC J Watkins, P Burton, S Leeder, et al.
Pageof 113